Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07037927 · ClinicalTrials.gov registry record · NA
Minnesota RETAIN Phase 3
A NA study of Disability and Injuries Related Work, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 1,000
- Enrollment target
- 1
- Study location
NCT07037927: Recruiting NA study of Disability and Injuries Related Work, sponsored by Mayo Clinic.
NCT07037927 is a NA study of Disability and Injuries Related Work that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,000 participants, below the 1,877-participant average among 3 other Disability trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07037927, a NA study of Disability and Injuries Related Work, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), and stakeholders throughout MN. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic a subrecipients of the grant.
Primary Outcome
Of the individuals participating, the number who achieve or maintain competitive integrated employment at the end of the enrollment period.
Conditions Studied
Interventions
- OTHER RETAIN Program
Study Locations (1)
Minnesota
- Mayo Clinic Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-07-07 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
What NCT07037927 shows while recruiting
NCT07037927 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,877-participant average among 3 other Disability trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Disability appearing as the primary indexed condition, and to 1 intervention - of which RETAIN Program is the first listed.
NCT07037927 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07037927 about?
NCT07037927 is a clinical study titled "Minnesota RETAIN Phase 3". MN RETAIN Phase 3 is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Education (DOE). There will be collaboration between partners ...
What is the current status of trial NCT07037927?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-07-07. Estimated completion is 2029-09-30.
What conditions does trial NCT07037927 study?
This clinical trial studies the following conditions: Disability, Injuries Related Work, Illness Related Work.
What interventions are being tested in trial NCT07037927?
The interventions under investigation include: RETAIN Program (OTHER).
Who is sponsoring clinical trial NCT07037927?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07037927 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI